Cancer immunotherapy and its facilitation by nanomedicine
Abstract Cancer immunotherapy has sparked a wave of cancer research, driven by recent successful proof-of-concept clinical trials. However, barriers are emerging during its rapid development, including broad adverse effects, a lack of reliable biomarkers, tumor relapses, and drug resistance. Integra...
Saved in:
Main Authors: | Chao Sui (Author), Heqing Wu (Author), Xinxin Li (Author), Yuhang Wang (Author), Jiaqi Wei (Author), Jianhua Yu (Author), Xiaojin Wu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomedicine for Combination Urologic Cancer Immunotherapy
by: Yun Tian, et al.
Published: (2023) -
Activation of cancer immunotherapy by nanomedicine
by: Lijuan Wang, et al.
Published: (2022) -
Light-responsive nanomedicine for cancer immunotherapy
by: Weirong Kang, et al.
Published: (2023) -
When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
by: Linna Yu, et al.
Published: (2022) -
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
by: Yanyan Xu, et al.
Published: (2022)